Nasal Alzheimer’s drug effective regardless of brain plaque levels

Researchers have found that an intranasal immunotherapy drug, currently being tested as a treatment for multiple sclerosis, reduced brain inflammation and improved cognition in mice with Alzheimer’s disease, independent of the amount of beta-amyloid plaques present. They say the treatment could benefit people in the later stages of the disease. Continue Reading Category: Medical, Science Tags: Alzheimer's Disease, Brain, Inflammatory, antibodies, Brigham and Women’s Hospital
http://dlvr.it/SwG0Yd

Popular Content

Daytime sleepiness is in your blood – but diet can help fight the fatigue

The Morning After: Meta gives up on fact checking for Facebook and Instagram

How to Increase Your Family's Wealth | VitalyTennant.com

One Snake, Two Venoms – And Both Are Lethal